Cardinal Health Unveils New Chinese Brand Name 'Jiadenuo', Reinforcing Commitment to China's Healthcare Sector

From left to right: Ms. Lian Jia, Academician Ge Junbo, Professor Qiao Shubin, Professor Nie Shaoping

On March 30, 2019, witnessed by numerous industry leaders, Cardinal Health (NYSE: CAH) unveiled its new Chinese brand name, “Jiadenou,” in Beijing. “Jia” signifies beauty and goodness, “De” denotes virtue, and “Nuo” represents commitment, conveying Cardinal Health’s dedication to fully considering customer preferences, adhering to business ethics, and firmly committing to meeting the needs of Chinese physicians and patients.

Cardinal Health, Inc. is a global, integrated healthcare services and products company that provides customized solutions to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices worldwide. By offering clinically proven medical products, pharmaceuticals, and cost-effective healthcare solutions, the company enhances supply chain efficiency from hospital to home. To help combat prescription drug abuse, Cardinal Health and its educational partners jointly established Generation Rx, a U.S.-based medication education and awareness program. With nearly 100 years of expertise, Cardinal Health employs approximately 50,000 people across nearly 46 countries, ranking 34th on the Fortune Global 500 and 14th on the Fortune 500. Its diversified healthcare business operates globally, with its core operations in China currently comprising two business segments: Vascular Intervention and Patient Recovery.

It is worth noting that its subsidiary brand, Contego, is a global provider of vascular interventional medical devices. Contego joined Cardinal Health in 2015, and this strategic partnership has enabled it to better help patients worldwide combat vascular diseases. Contego has achieved numerous “industry firsts” in the field of vascular intervention globally, continuously delivering innovative solutions to healthcare professionals around the world. Widely recognized within the industry, Contego is one of the leaders in the fields of cardiac and peripheral vascular care.

Ms. Lian Jia, General Manager of Cardinal Health’s Medical Segment in China, stated at the unveiling ceremony, “As one of the global leaders in the medical products and medical device industry, Cardinal Health brings nearly a century of professional expertise to deliver high-quality, clinically validated healthcare solutions that safeguard patient health. We are committed to deepening our presence in the local market and working alongside our partners to provide customized, high-quality products and healthcare solutions for physicians, nurses, and patients.”

Ms. Lian Jia

Ms. Lian Jia joins hands with top domestic cardiovascular experts: Professor Ge Junbo, Academician of the Chinese Academy of Sciences and Director of the Department of Cardiology at Zhongshan Hospital, ChinaMedicineProfessor Qiao Shubin, Director of the Coronary Heart Disease Center at Fuwai Hospital, Chinese Academy of Medical Sciences, and Professor Nie Shaoping, Director of the Emergency and Critical Care Center at Beijing Anzhen Hospital, Capital Medical University, jointly unveiled the new Chinese name—Jiadenou—at the press conference.

Over the past few years, Cardinal Health has expanded its development in China through a series of strategic initiatives. By continuously investing in its Cordis business, Cardinal Health has been able to further meet the needs of domestic patients in the cardiovascular field, providing trustworthy and innovative solutions for patients while achieving solid business growth. Following the divestiture of its China distribution business in 2018, Cardinal Health completed the integration of Medtronic’s patient recovery business in China in early 2019, diversifying and deepening its medical product portfolio. These measures have further strengthened Cardinal Health’s ability to provide healthcare professionals with reliable, high-quality products and medical solutions throughout the entire patient care journey.

Prof. Shaoping Nie

Professor Nie Shaoping stated, “The modern healthcare model is undergoing a rapid transformation, an ongoing process of evolution and development. Enterprises, medical product and service providers, and we physicians must continuously adapt to this shift. What remains unchanged, however, are our shared values and commitment to patients. As Cardinal Health embarks on a new chapter, upholding our common commitment, we look forward to creating a healthier future for patients and fostering even closer collaboration along this united front.”

Prof. Shubin Qiao

This year also marks the 60th anniversary of Cordis. Professor Qiao Shubin stated, “As one of the pioneers in the development of products and technologies in the field of cardiovascular intervention, Cordis has played a significant role in delivering leading-edge products to numerous patients and providing clinical training to many healthcare professionals.”

Academician Ge Junbo

“The prevalence of cardiovascular disease in China continues to rise, with one in every five adults affected. Only by pooling resources from all sectors can we more effectively address this major public health challenge,” said Academician Ge Junbo. “We have made significant progress over the past years, and we welcome partners such as Cardinal Health to jointly promote the development of cardiovascular health in China.”